Type 1 diabetes is a form of diabetes mellitus in which very little or no insulin is produced by the pancreas.
The global type 1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies.
In 2017, the global Type 1 Diabetes market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Type 1 Diabetes status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Type 1 Diabetes development in United States, Europe and China.
The key players covered in this study
Abbott
Bayer
Eli Lilly
BD
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Roche
Smiths Medical
Medtronic
Market segment by Type, the product can be split into
Rapid-acting
Long-acting
Premix
Market segment by Application, split into
Hospitals
Diagnostic clinics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Type 1 Diabetes status, future forecast, growth opportunity, key market and key players.
To present the Type 1 Diabetes development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Type 1 Diabetes are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.